Riverview Trust Company’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-128
Closed -$33.9K 383
2025
Q1
$33.9K Buy
+128
New +$34.6K 0.03% 277
2024
Q4
Sell
-121
Closed -$38.3K 868
2024
Q3
$38.3K Buy
121
+2
+2% +$712 0.03% 282
2024
Q2
$44.5K Buy
+119
New +$40.2K 0.04% 242
2023
Q4
Sell
-88
Closed -$42.8K 336
2023
Q3
$42.8K Hold
88
0.04% 255
2023
Q2
$39.3K Hold
88
0.04% 238
2023
Q1
$42.7K Hold
88
0.04% 231
2022
Q4
$45K Hold
88
0.04% 229
2022
Q3
$43K Hold
88
0.04% 231
2022
Q2
$41K Buy
88
+15
+21% +$6.67K 0.04% 236
2022
Q1
$32K Buy
+73
New +$30.5K 0.02% 298

Other funds holding HUM

Riverview Trust Company's HUM Position: Q2 2025 in Review

Riverview Trust Company sold out of Humana (HUM) in Q2 2025, closing a stake of 128 shares — an estimated $33.9K sold.

Riverview Trust Company first reported a position in HUM in Q1 2022 and held it in 10 quarters. The position peaked at $45K in Q4 2022. 878 funds tracked by Wall St. Rank hold HUM as of Q2 2025.

  • Riverview Trust Company reported no remaining Humana position as of Q2 2025 after selling out during the quarter.
  • Riverview Trust Company sold 128 Humana shares in Q2 2025, an estimated $33.9K.
  • Riverview Trust Company first reported a position in Humana in Q1 2022 and held it in 10 quarters.
  • Riverview Trust Company's Humana position peaked at $45K in Q4 2022.
  • 878 funds tracked by Wall St. Rank held Humana as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.